Management of musculoskeletal pain: an update with emphasis on chronic musculoskeletal pain

SN El-Tallawy, R Nalamasu, GI Salem, JAK LeQuang… - Pain and therapy, 2021 - Springer
Musculoskeletal pain is a challenging condition for both patients and physicians. Many
adults have experienced one or more episodes of musculoskeletal pain at some time of their …

[HTML][HTML] Epidural interventions in the management of chronic spinal pain: American Society of Interventional Pain Physicians (ASIPP) comprehensive evidence-based …

L Manchikanti, NN Knezevic, A Navani… - Pain …, 2021 - institutionalrepository.aah.org
BACKGROUND: Chronic spinal pain is the most prevalent chronic disease with employment
of multiple modes of interventional techniques including epidural interventions. Multiple …

[PDF][PDF] Expanded umbilical cord mesenchymal stem cells (UC-MSCs) as a therapeutic strategy in managing critically ill COVID-19 patients: the case for compassionate …

S Atluri, L Manchikanti, JA Hirsch - Pain physician, 2020 - sah.org.ar
2. Institute appropriate safeguards to avoid negative consequences from unscrupulous
actors. 3. With proper informed consent from patients or proxy when necessary, and subject …

Comprehensive evidence-based guidelines for facet joint interventions in the management of chronic spinal pain: American Society of Interventional Pain Physicians …

L Manchikanti, AD Kaye, A Soin… - Pain …, 2020 - scholarlycommons.pacific.edu
Background: Chronic axial spinal pain is one of the major causes of significant disability and
health care costs, with facet joints as one of the proven causes of pain. Objective: To provide …

The immune system as a target for therapy of SARS-CoV-2: a systematic review of the current immunotherapies for COVID-19

AH Mansourabadi, M Sadeghalvad… - Life sciences, 2020 - Elsevier
Aims The immune response is essential for the control and resolution of viral infections.
Following the outbreak of novel coronavirus disease (COVID-19), several immunotherapies …

Mesenchymal stromal cell therapy for COVID-19-induced ARDS patients: a successful phase 1, control-placebo group, clinical trial

N Kaffash Farkhad, A Sedaghat, H Reihani… - Stem Cell Research & …, 2022 - Springer
Background Acute respiratory distress syndrome (ARDS) is the devastating complication of
the new COVID-19 pandemic, directly correlated with releasing large amounts of …

[PDF][PDF] Spinal cord stimulation trends of utilization and expenditures in fee-for-service (FFS) Medicare population from 2009 to 2018

L Manchikanti, V Pampati, BP Vangala… - Pain …, 2021 - painphysicianjournal.com
Background: Spinal cord stimulation has been utilized with increasing frequency in
managing chronic intractable spinal pain and complex regional pain syndrome (CRPS) in …

Bone marrow aspirate concentrate versus platelet rich plasma or hyaluronic acid for the treatment of knee osteoarthritis

O Dulic, P Rasovic, I Lalic, V Kecojevic, G Gavrilovic… - Medicina, 2021 - mdpi.com
Background: In the last decade, regenerative therapies have become one of the leading
disease modifying options for treatment of knee osteoarthritis (OA). Still, there is a lack of …

The safety and effectiveness of orthobiologic injections for discogenic chronic low back pain: a multicenter prospective, crossover, randomized controlled trial with 12 …

A Navani, M Ambach, A Calodney… - Pain …, 2024 - search.proquest.com
BACKGROUND: Chronic low back pain is one of the most common causes of disability,
affecting more than 600 million people worldwide with major social and economic costs …

[HTML][HTML] Research progress on mesenchymal stem cells (MSCs), adipose-derived mesenchymal stem cells (AD-MSCs), drugs, and vaccines in inhibiting COVID-19 …

P Gentile, A Sterodimas, J Pizzicannella… - Aging and …, 2020 - ncbi.nlm.nih.gov
Abstract Mesenchymal Stem Cells (MSCs), and Adipose-Derived Mesenchymal Stem Cells
(AD-MSCs) have been used for many years in regenerative medicine for clinical and …